|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
GTX30957
|
GeneTex International Corporation
|
Protein A (PE)
|
|
FACS, ICC/IF
|
|
|
GTX30958
|
GeneTex International Corporation
|
Protein A (FITC)
|
|
FACS, ICC/IF
|
|
|
HY-100014-1mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-10mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-100mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-5mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100014-50mg
|
MedChemexpress LLC
|
KDM5A-IN-1 [CAS 1905481-36-8]
|
|
Cancer-programmed cell death
|
|
|
HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100277-1mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100277-5mg
|
MedChemexpress LLC
|
Mifobate [CAS 76541-72-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100359-10mg
|
MedChemexpress LLC
|
CL-82198 [CAS 307002-71-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100359-100mg
|
MedChemexpress LLC
|
CL-82198 [CAS 307002-71-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100359-25mg
|
MedChemexpress LLC
|
CL-82198 [CAS 307002-71-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100359-5mg
|
MedChemexpress LLC
|
CL-82198 [CAS 307002-71-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100359-50mg
|
MedChemexpress LLC
|
CL-82198 [CAS 307002-71-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100360-10mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-100mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-25mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-5mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100360-50mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
